Melissa Officinalis effect on sleep quality and anxiety in patients with acute coronary syndrome

The effect of Melissa officinalis on sleep quality and anxiety in patients who suffer from acute coronary syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017070234851N1

Enrollment

Registered

2017-08-21

Start date

2017-08-11

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute coronary syndrome. Acute ischaemic heart disease, unspecified

Interventions

Intervention 1: Case group receives 2 grams Melissa Officinalis (4 capsules contains 500 mg Melissa Officinalis daily) for 7 days. Intervention 2: control group receives 2 grams starch powder daily (4

Treatment - Drugs

Case group receives 2 grams Melissa Officinalis (4 capsules contains 500 mg Melissa Officinalis daily) for 7 days

control group receives 2 grams starch powder daily (4 capsules contains 500 mg starch powder daily) for 7 days

Eligibility

Sex/Gender

All

Age

30 Years to 80 Years

Inclusion criteria

Inclusion criteria: Entry criteria: company in the study; patients tend to benefit from mental health; not having the experience of sleep disorder before bed; having full consciousness and able to communicate; having no history of chronic pain; addiction to alcohol and drugs; having at least 30 years of age up to 80; the first patient to be hospitalized; the ability to turn taking medication orally; the history of Sleep apnea and COPD; while according to the rating criteria for differentiating diagnosis of Pittsburgh sleep disorder questionnaire before bed with sleep disturbances caused by the patient's hospitalization if you get 0-4 points will be studied; the history of PCI. Exit criteria: cancel the patient's continued cooperation; the patient's feet

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Sleep quality. Timepoint: before intervention- at the end of intervention. Method of measurement: Richards-Campbell Sleep Questionnaire (RCSQ).;Anxiety. Timepoint: before intervention- at the end of intervention. Method of measurement: Spielberger State-Trait Anxiety Inventory (STAI).	—

Secondary

Measure	Time frame
The side effects of medication. Timepoint: before intervention- at the end of intervention. Method of measurement: Side effects form of medication.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Emami

Faculty of Nursing and Midwifery Shahed

m.emami@shahed.ac.irm.emami7727@gmail.ir+98 21 6641 8587

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026